Manufactures agrochemicals, specialty chemicals, pharmaceutical intermediates and industrial chemicals from three plants in India, with the bulk of activity falling under performance chemicals. Revenue is earned by selling these products to global agrochemical formulators, CDMO customers in Japan and Europe, and food-grade phosphoric acid to global beverage companies. Exports made up 43% of FY26 revenue of Rs 1,029.8 crore, with Europe accounting for around 70% of those exports. The portfolio is being widened with 4-5 new products commercialised each year — new products were 14% of Q1 FY27 revenue and are guided to reach 15-18% in FY27 — and 25-plus products sit in the R&D pipeline. Manufacturing expansion is underway: the Laulu block is targeted to complete in FY27, and a new greenfield site is under evaluation alongside Rs 100 crore of planned capex for two multipurpose plants. Raw materials form the biggest cost line at 60.4% of revenue. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Agrochemicals, Specialty and performance chemicals, Pharmaceutical intermediates, Industrial chemicals. Specialty chemicals and agrochemicals manufacturer, mid-scale and export-oriented, with diversified end-uses across crop protection, pharma, food and industrial.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 933 | 1,006 | 934 | 901 | 1,030 |
| EBITDA (ex other income) | 140 | 123 | 113 | 95 | 116 |
| margin % | 15.0 | 12.2 | 12.1 | 10.6 | 11.3 |
| Owners' profit | 0 | 61 | 0 | 0 | 64 |
| EPS, as reported (₹) | 68.07 | 49.84 | 43.70 | 31.75 | 52.17 |
| ROE % · ROCE % | 37.0 · 40.3 | 21.8 · 28.8 | 16.2 · 23.3 | 10.7 · 15.7 | 15.1 · 20.7 |
| Debt / equity (x) | 0.41 | 0.33 | 0.37 | 0.46 | 0.36 |
| Cash from operations | 34 | 58 | 30 | 25 | 86 |
| Capex | (33) | (37) | (33) | (34) | (46) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 242 | 214 | 202 | 320 | 255 | 247 | 209 | 347 |
| Profit before tax | 17 | 8 | 10 | 28 | 22 | 19 | 16 | 30 |
| Net profit | 12 | 6 | 7 | 21 | 19 | 14 | 11 | 22 |
| EPS (₹) | 10.09 | 4.95 | 5.75 | 16.83 | 15.12 | 11.26 | 8.96 | 18.00 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UPL LIMITED | 48,414 | 23.7 | 1.17 | 6.5 | 5.4 | 5.5 | 6.0 | 16.3 |
| PI INDUSTRIES LTD | 34,337 | 29.4 | 3.06 | 16.2 | 11.8 | 14.5 | 8.0 | 25.3 |
| SUMITOMO CHEM INDIA LTD | 23,762 | 41.0 | 7.00 | 29.6 | 16.0 | 20.8 | 4.1 | 28.9 |
| BAYER CROPSCIENCE LTD | 17,895 | 26.0 | 6.03 | — | 23.2 | 27.3 | — | 22.7 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 26 Aug 2026 · Court relief in IGST demand case worth about Rs 44.96 crore | regulatory legal | high | — | — |
| 26 Aug 2026 · Punjab Chemicals to meet Fortitude Fund on Sept 1, 2026 | board shareholder meetings | low | — | — |
| 20 Aug 2026 · Analyst meet with Swan Investments on 25 Aug 2026 at 3 PM | board shareholder meetings | low | — | — |
| 5 Aug 2026 · Q1 FY27 earnings call transcript filed with exchanges | investor communications | medium | — | — |
| 5 Aug 2026 · Transcript of Q1 FY27 earnings call made available on company website | investor communications | medium | — | — |
| 1 Aug 2026 · 50th AGM Results: All 6 Resolutions Passed, Dividend Declared | board shareholder meetings | low | — | — |
| 1 Aug 2026 · Newspaper publication of Q1 FY27 unaudited results | compliance | minimal | — | — |
| 31 Jul 2026 · 50th AGM held; Rs.3 per share dividend recommended for FY2026 | board shareholder meetings | low | — | — |
| 31 Jul 2026 · Q1 FY27 Earnings Call Audio Recording Uploaded | investor communications | low | — | — |
| 31 Jul 2026 · Punjab Chemical Q1 PAT up 10% at Rs 22 cr; Director Avtar Singh resigns | management changes | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| SHARDA CROPCHEM LTD. |
| 6,910 |
| 11.0 |
| 2.20 |
| 5.7 |
| 21.7 |
| 25.2 |
| 17.1 |
| 20.5 |
| DHANUKA AGRITECH LTD | 4,359 | 14.9 | 3.11 | 9.7 | 21.2 | 27.0 | 12.7 | 27.4 |
| RALLIS INDIA LTD | 3,833 | 23.9 | 2.26 | 12.9 | 9.7 | 12.5 | — | 0.9 |
| NACL INDUSTRIES LIMITED | 3,709 | 310.4 | 5.43 | 45.4 | 0.7 | 1.4 | 5.9 | 11.3 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 20.1 | 20.1 | 14 of 27 | 50% |
| P/B | 3.1 | 2.4 | 21 of 28 | 22% |
| ROCE | 17.3 | 12.5 | 7 of 29 | 79% |
| ROE | 15.1 | 9.2 | 6 of 28 | 82% |
| Debt / Equity | 0.4 | 0.3 | 17 of 29 | 43% |
| EBITDA margin | 11.9 | 14.8 | 17 of 28 | 41% |
| Revenue growth | 8.7 | (0.8) | 8 of 28 | 74% |
| Profit growth | 7.0 | 18.1 | 18 of 28 | 37% |
| Market cap | 1315 | 1540 | 16 of 29 | 46% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
